Legend Biotech CEO Ying Huang On Moving Fast In the BCMA CAR-T Race
Chinese Firm Is Partnered With Second Place Contender Janssen In US
Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.
